<DOC>
	<DOCNO>NCT02463721</DOCNO>
	<brief_summary>Several study point change epidemiology causative bacteria SBP bacterascites susceptibility antibiotic . In particular , development beta-lactamase enzyme , confer resistance clavulanate , extend spectrum beta-lactamase Escherichia coli . The potential emergence enterococci , methicillin-resistant S. aureus , fluoroquinolone-resistant bacteria , follow norfloxacin prophylaxis , also cause concern since may associate high risk therapeutic failure . The microbial etiology SBP remain relatively constant ; however , antibiotic resistance rate especially third-generation cephalosporin ( include cefotaxime ceftazidime ) , ciprofloxacin , ofloxacin increase dramatically</brief_summary>
	<brief_title>Identification Ascitic Fluid Bacterial Pathogens Spontaneous Bacterial Peritonitis</brief_title>
	<detailed_description>Spontaneous bacterial peritonitis ( SBP ) , define infection ascites absence contiguous source infection . Spontaneous bacterial peritonitis ( SBP ) common potentially fatal bacterial infection patient cirrhosis ascites , occur 10 30 % patient , in-hospital mortality rate range 20 30 % . It secondary impaired humoral cellular immune response result indirect intestinal bacterial translocation ascitic fluid . SBP also associate poor long-term prognosis patient , mortality rate reach 50 70 % 1 year . Early diagnosis early optimal treatment infection appropriate antibiotic prevention hepatorenal syndrome albumin require . Current European international guideline recommend use third-generation cephalosporin first choice , amoxicillin-clavulanate acid fluoroquinolones alternative choice . These recommendation base mainly clinical trial often conduct decade ago , assumption E. coli would involve nearly half case . Several study point change epidemiology causative bacteria SBP bacterascites susceptibility antibiotic . In particular , development beta-lactamase enzyme , confer resistance clavulanate , extend spectrum beta-lactamase Escherichia coli.The potential emergence enterococci , methicillin-resistant S. aureus , fluoroquinolone-resistant bacteria , follow norfloxacin prophylaxis , also cause concern since may associate high risk therapeutic failure .</detailed_description>
	<mesh_term>Peritonitis</mesh_term>
	<criteria>Liver cirrhosis ascites suspect SBP . ascitic fluid PMNL â‰¥ 250 cells/mm3 ascitic fluid polymicrobial infection patient start empirical antibiotic without prior culture .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>sbp</keyword>
	<keyword>culture</keyword>
</DOC>